AAP Pharma Technologies

What AAP Pharma Technologies does

AAP Pharma Technologies India (P) Ltd is a privately held, founder-owned contract research and contract development/manufacturing organization (CRO/CDMO) founded in late 2008 by Sreenu Guntha and headquartered in Genome Valley, Hyderabad. The company provides custom synthesis, process research and development (R&D), route scouting and optimization, kilo lab synthesis, reference standard synthesis, and medicinal chemistry library services to overseas pharmaceutical and biotechnology clients. Core technical operations run from a 30,000 square foot state-of-the-art facility built in 2019 that houses dedicated R&D laboratories, an analytical facility (HPLC, UPLC, mass spectrometry, GC-MS, GC-HS, prep-HPLC, flash chromatography, KF titration, melting point), a kilo lab, and a 12-seater conference hall. Larger-scale manufacturing (up to 5,000L, including cryogenic capability) is delivered through a strategic partnership with Syntho Chirals in Bidar, with pilot-scale capacity via Sainor and analytical method development/validation supported by Laxai and Daicel. AAP's go-to-market is direct B2B project-based sales targeting global pharma and biotech, led from the US by project consultant Greg Reid (PhD Wisconsin, postdoc Harvard) and supported by a bench of PhD scientists drawn from elite global CROs and academic institutions (Carnegie Mellon, ETH Zurich/Scripps lineage, CSIR-IICT, Universite de Rennes). Revenue is generated through quote-based project fees for custom synthesis and process R&D services, with pricing varying by molecular complexity, scale (milligram to multi-kilogram), regulatory conditions (GMP vs non-GMP), and timeline.

Name

AAP Pharma Technologies

Legal name

AAP Pharma Technologies India (P) Ltd

Website

https://aap-pharmatech.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

AAP Pharma Technologies is a privately held Hyderabad-based CRO/CDMO offering custom synthesis, process R&D, kilo lab synthesis, reference standards, and medicinal chemistry services to global pharmaceutical and biotech clients from a 30,000 sft Genome Valley facility.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Research and Manufacturing Services (CRO/CDMO)

NAICS

Scientific Research and Development Services (5417), Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule API Process Development & Route Scouting (HLAGAHAA)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Custom pharmaceutical synthesis
• Contract research services
• Process R&D
• API manufacturing
• Medicinal chemistry

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Custom Synthesis Services: Project-based custom synthesis engagements for pharmaceutical companies requiring reference standards, key intermediates, and API synthesis. Pricing per project based on complexity and scale requirements.
2. Process R&D Services: Process research and development services including route scouting, optimization, and scale-up. Revenue generated through project fees and milestone-based payments.
3. Analytical Development Services: Analytical method development, validation, and technology transfer services supporting drug development programs across different clinical phases.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

AAP Pharma Technologies provides custom synthesis and contract research services for pharmaceutical and biotechnology clients, including process R&D, route scouting and optimization, kilo lab scale-up synthesis, reference standard synthesis, medicinal chemistry library synthesis, and analytical method development. It operates a 30,000 sq ft R&D facility in Genome Valley, Hyderabad, with capabilities from milligram to multi-kilogram scale and coordinates with Syntho Chirals for commercial-scale manufacturing via reactors up to 5000L.

Product overview

AAP Pharma Technologies India (P) Ltd is a Contract Research and Manufacturing Services (CRO/CDMO) company offering a comprehensive suite of pharmaceutical development services. The core offering consists of Custom Synthesis Services, Process R&D, Kilo Lab Synthesis, and Large Scale Manufacturing (via Syntho Chirals partnership). Supporting services include Reference Standard Synthesis, Analytical Services (method development and validation), and Medicinal Chemistry Services. The company operates from a 30,000 sq ft state-of-the-art facility in Genome Valley, Hyderabad, providing integrated services from early-phase drug development through commercial-scale API synthesis.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Synthesis Services Custom synthesis of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for pharmaceutical and biotech clients, covering process R&D, scale-up from milligram to multi-kilogram, and kilo lab synthesis.
• Process R&D Process research and development services including route scouting, process optimization, and development for APIs across phases of clinical development, with the stated capability to move from idea to experiment in 15 minutes or less.
• Kilo Lab Synthesis

Quantifiable outcome

• Process development from idea to experiment in 15 minutes or less
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Syntho ChiralscoreStrategic or Co-development PartnerFor large scale manufacturing requirements AAP uses Syntho Chirals, which has a well-equipped manufacturing plant in Bidar (3-hour drive from AAP). They have reactors capable of cryogenic temperatures and up to 5000L for very large scale synthesis. All AAP reactions at Syntho Chirals are carried out by AAP staff who are housed in Bidar for the duration of the project.
• SainorminorStrategic or Co-development PartnerPilot plant scale manufacturing partner for scaling up synthesis processes.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Anthem Biosciences: Bangalore-based CRO/CDMO offering custom synthesis, medicinal chemistry, and process R&D — competes for the same India-based custom synthesis and process development work as AAP.
• Syngene International: Publicly listed Indian CRO/CDMO providing custom synthesis, process R&D, and API development services to global pharma — overlaps directly with AAP's core offering and competes for the same custom synthesis mandate pipeline.
• Curia (formerly Albany Molecular Research Inc.): Global CDMO offering process R&D, route scouting, and small-molecule API manufacturing — closely matches AAP's custom synthesis and process development focus, and is a recurring prior employer on AAP's leadership bench.
• Aragen Life Sciences (formerly GVK Bio): Hyderabad-based CRO/CDMO with discovery, process R&D, and API manufacturing capabilities — prior employer of an AAP senior scientist and a directly comparable Indian contract research services competitor.
• Cambrex: Global small-molecule CDMO with deep process R&D and API manufacturing capabilities — closely aligned with AAP's custom synthesis focus, and a previous employer of AAP's US consultant at the Centre for Technical Excellence.
• Sai Life Sciences: Hyderabad-based integrated CRO/CDMO offering discovery, process R&D, and API manufacturing — directly comparable as a Tier-1 Indian CRO serving global pharma, and is the firm from which AAP's founder and several senior scientists originated.
• PCI Synthesis (now Seqens): US-headquartered custom synthesis and process R&D CDMO — Greg Reid, AAP's US project consultant, was previously VP of Technology here, indicating strong operational and cultural overlap with AAP's service model.
• Piramal Pharma Solutions: Global CDMO with strong process R&D and API manufacturing capabilities in India — competes for custom synthesis and scale-up mandates of the type AAP serves, and is also a prior employer for an AAP group leader.
• Chemveda Life Sciences: Hyderabad-based CRO/CDMO offering process chemistry, custom synthesis, and API development — directly comparable in scale and service mix to AAP, and a prior employer of an AAP group leader.

Broad incumbents

• Laurus Labs: Larger publicly listed Hyderabad-headquartered pharmaceutical manufacturer covering APIs, generics, and CDMO services — broader scope than AAP but co-located in Genome Valley and competes for some of the same process R&D and API scale-up mandates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/login

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AAP Pharma Technologies